On that news, Allscripts’ stock price dropped 11 percent on Nov. 30, though it fell by only 2 cents more in late morning trading on Dec. 3. Allscripts on Nov. 8 reported weak financial performance for the third quarter of 2012, saying providers were deferring purchase decisions and waiting for new product releases. CEO Glen Tullman confirmed the company was evaluating “strategic alternatives,” which Bloomberg News first reported in October. Tullman blamed the “noise” of acquisition talk on lower bookings in the third quarter and said, “We think we’ll be well-positioned once we get past the noise.”
Reuters then reported on Nov. 14 that Blackstone Group, Carlyle Group and TPG Capital had submitted second-round offers to Allscripts.





























How do I know anything more then just another opinion - my world - administrator in a small medical group practice. Look what's happening to small private practice. The cost of medical school, the fast-paced technical changes in disease management and other medical procedures, accelerating high-tech tools and system for diagnosis - same thing. You have to build a sustainable model into your business strategy that is radically different from "old-line thinking" while improving access, patient satisfaction, and costs of delivery. We can produce a bottom line with a false sense of profitability, looking at an annual picture - but are we really covering debt and costs from just the few things I mentioned? We have set about thinking radically on how to change the medical practice that we all still want to work in, and it really does require going "out of the box". At first, just the thought was traumatic - but now, inch by inch we are getting there. And the most unreliable sources of help have been the Feds, big hospital systems, miss-guided tech vendors, and medical institutions that want quick fixes and control - all big, and all overnight. It isn't going to happen that way, but it is achievable.